Co‑hosted by Cambridge Enterprise, LGC Group and the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB).

Celebrating his return to Cambridge and the MRC Laboratory of Molecular Biology (LMB), we are delighted to welcome Professor Harvey Lodish, Professor of Biology and Biological Engineering at MIT, who undertook his postdoctoral research at the LMB with Drs Sydney Brenner and Francis Crick, for a special lecture and discussion.

The event will explore how fundamental scientific discovery can be translated into real‑world benefit and the role universities play in supporting that journey with integrity, responsibility, and long‑term vision.

Professor Lodish will share insights from his academic career and his experience co-founding co-founding biotechnology companies Genzyme and Millennium Pharmaceuticals, including perspectives on mentorship, ethics, and the relationship between research excellence and commercialising technology. The lecture will be followed by a panel discussion, Q&A, and networking over lunch.

This unique opportunity is open to academics, postdoctoral researchers, and staff from across the Biomedical Campus, including the LMB, Clinical Schools, Milner Therapeutics Institute, and partner organisations.

Event details

Date: Tuesday 21 July 2026
Venue: MRC Laboratory of Molecular Biology, Francis Crick Ave, Cambridge Biomedical Campus, Cambridge CB2 0QH
Timings: 10.00am-1.30pm